$313 Million is the total value of Tri Locum Partners LP's 61 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 194.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | New | AMGEN INC | $28,886,325 | – | 107,480 | +100.0% | 9.24% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $26,855,509 | +222.5% | 2,632,893 | +138.1% | 8.59% | +177.4% |
| DXCM | Buy | DEXCOM INC | $24,946,554 | +274.8% | 267,380 | +416.2% | 7.98% | +222.4% |
| ABBV | New | ABBVIE INC | $21,548,263 | – | 144,561 | +100.0% | 6.89% | – |
| SPY | New | SPDR S&P 500 ETF TRtr unit | $19,325,516 | – | 45,208 | +100.0% | 6.18% | – |
| CTLT | Buy | CATALENT INC | $13,021,534 | +49.4% | 285,999 | +42.3% | 4.16% | +28.5% |
| NTRA | Buy | NATERA INC | $12,159,679 | +371.8% | 274,795 | +418.8% | 3.89% | +305.8% |
| New | GE HEALTHCARE TECHNOLOGIES I | $8,968,352 | – | 131,810 | +100.0% | 2.87% | – | |
| SILK | Buy | SILK RD MED INC | $8,040,516 | +24.7% | 536,392 | +170.2% | 2.57% | +7.3% |
| ARGX | New | ARGENX SEsponsored adr | $7,052,924 | – | 14,346 | +100.0% | 2.26% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $6,809,775 | -14.4% | 6,247,500 | +52.4% | 2.18% | -26.4% |
| IMGN | Buy | IMMUNOGEN INC | $5,870,503 | +4.5% | 369,912 | +24.2% | 1.88% | -10.1% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $5,867,151 | +529.2% | 171,755 | +609.1% | 1.88% | +440.6% |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $5,337,037 | – | 208,886 | +100.0% | 1.71% | – |
| New | NUVALENT INC | $5,218,882 | – | 113,528 | +100.0% | 1.67% | – | |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $5,184,639 | +62.2% | 318,076 | +110.4% | 1.66% | +39.6% |
| New | AMYLYX PHARMACEUTICALS INC | $5,179,203 | – | 282,862 | +100.0% | 1.66% | – | |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $5,043,298 | +408.6% | 821,384 | +418.5% | 1.61% | +337.1% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $4,930,456 | -17.9% | 33,761 | +29.8% | 1.58% | -29.4% |
| Buy | ASTRIA THERAPEUTICS INC | $4,462,035 | +139.1% | 598,128 | +166.9% | 1.43% | +105.6% | |
| GKOS | New | GLAUKOS CORP | $4,231,308 | – | 56,230 | +100.0% | 1.35% | – |
| ETNB | Buy | 89BIO INC | $3,853,376 | +22.6% | 249,571 | +50.4% | 1.23% | +5.5% |
| IMTX | Buy | IMMATICS N.V | $3,531,599 | +273.0% | 304,974 | +271.7% | 1.13% | +220.7% |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,038,100 | – | 53,300 | +100.0% | 0.97% | – | |
| AZN | New | ASTRAZENECA PLCsponsored adr | $2,995,526 | – | 44,234 | +100.0% | 0.96% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $2,441,498 | – | 8,353 | +100.0% | 0.78% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $2,250,216 | – | 251,702 | +100.0% | 0.72% | – |
| New | ACELYRIN INC | $1,582,177 | – | 155,573 | +100.0% | 0.51% | – | |
| New | KENVUE INCcall | $1,104,400 | – | 55,000 | +100.0% | 0.35% | – | |
| MORF | New | MORPHIC HLDG INC | $838,643 | – | 36,606 | +100.0% | 0.27% | – |
| GERN | New | GERON CORP | $807,892 | – | 381,081 | +100.0% | 0.26% | – |
| HIG | Buy | HARTFORD FINL SVCS GROUP INC | $248,185 | +13.6% | 3,500 | +15.4% | 0.08% | -2.5% |
| ANTM | New | ELEVANCE HEALTH INC | $247,319 | – | 568 | +100.0% | 0.08% | – |
| UPS | New | UNITED PARCEL SERVICE INCcl b | $221,803 | – | 1,423 | +100.0% | 0.07% | – |
| YUM | New | YUM BRANDS INC | $218,770 | – | 1,751 | +100.0% | 0.07% | – |
| ITW | New | ILLINOIS TOOL WKS INC | $214,649 | – | 932 | +100.0% | 0.07% | – |
| TEL | New | TE CONNECTIVITY LTD | $213,954 | – | 1,732 | +100.0% | 0.07% | – |
| HSY | New | HERSHEY CO | $204,082 | – | 1,020 | +100.0% | 0.06% | – |
| FAST | New | FASTENAL CO | $200,201 | – | 3,664 | +100.0% | 0.06% | – |
| PEAK | New | HEALTHPEAK PROPERTIES INC | $187,547 | – | 10,215 | +100.0% | 0.06% | – |
| RXRX | New | RECURSION PHARMACEUTICALS INunit | $171,903 | – | 22,471 | +100.0% | 0.06% | – |
| PSEC | New | PROSPECT CAP CORP | $169,140 | – | 27,957 | +100.0% | 0.05% | – |
| AM | Buy | ANTERO MIDSTREAM CORP | $161,107 | +19.0% | 13,448 | +15.2% | 0.05% | +4.0% |
| RES | New | RPC INC | $107,915 | – | 12,071 | +100.0% | 0.04% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $99,439 | – | 10,326 | +100.0% | 0.03% | – |
| UAA | New | UNDER ARMOUR INCcl a | $88,392 | – | 12,904 | +100.0% | 0.03% | – |
| SWN | New | SOUTHWESTERN ENERGY CO | $88,320 | – | 13,693 | +100.0% | 0.03% | – |
| GCMG | New | GCM GROSVENOR INC | $79,377 | – | 10,229 | +100.0% | 0.02% | – |
| NMRK | New | NEWMARK GROUP INCcl a | $73,411 | – | 11,417 | +100.0% | 0.02% | – |
| JBLU | Buy | JETBLUE AWYS CORP | $68,779 | -44.1% | 14,952 | +7.6% | 0.02% | -52.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.